Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
losartan (losartan potassium)
Denk Pharma GmbH & Co. KG
C09CA01
losartan (losartan potassium)
100mg
tablets film-coated
(28/2x14/) in blister
Prescription
Registered
2022-08-22
_Losar-Denk 100_ Film-coated tablet – oral use Angiotensin II receptor antagonist Active substance: losartan Package leaflet: Information for the patient READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. – Keep this leaflet. You may need to read it again. – If you have any further questions, ask your doctor or pharmacist. – This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. – If you get any side effects, talk to your doctor or phar - macist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. WHAT LOSAR-DENK 100 IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE LOSAR-DENK 100 3. HOW TO TAKE LOSAR-DENK 100 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE LOSAR-DENK 100 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. What Losar-Denk 100 is and what it is used for Losartan belongs to a class of drugs known as angiotensin II receptor antagonists. The substance angiotensin II is formed in your body and helps to regulate your blood pressure. It binds to receptors in the blood vessels making them narrower. This causes your blood pressure to rise. When blood pressure is high, angiotensin II plays a part in maintaining the elevated blood pressure. Losartan prevents angiotensin II from binding to these receptors so that the blood vessels can relax and your blood pressure drops. Losartan slows down renal impairment in patients with high blood pressure and type-2 diabetes. Losar-Denk 100 is used • in the treatment of patients with high blood pressure (hypertension) in adults and in children and adolescents 6 - 18 years of age. • to protect the kidneys of patients with high blood pressure and type-2 diabetes mellitus along with impaired kidney function proven by blood tests, with a urinary protein excretion of ≥ 0.5 g/day (this disease is associated with pathologically high Read the complete document
1 S UMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Losar-Denk 100 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: losartan Each film-coated tablet contains 100 mg losartan potassium, equivalent to 91.6 mg losartan. Excipient with known effect: Each film-coated tablet contains 70 mg of lactose monohydrate. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. White to off-white, round, biconvex film-coated tablet with a break-line on one side, plain on the other side, without facet. The film-coated tablets can be divided into equal doses. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS - Treatment of essential hypertension in adults and in children and adolescents 6 - 18 years of age. - Treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus with proteinuria ≥ 0.5 g/day as part of an antihypertensive treatment (see sections 4.3, 4.4, 4.5 and 5.1). Treatment of chronic heart failure in adult patients when treatment with Angiotensin-Converting Enzyme (ACE)-inhibitors is not considered suitable due to incompatibility, _especially cough_, or contraindication. Patients with heart failure who have been stabilised with an ACE-inhibitor should not be switched to losartan. Patients should have a reduced left ventricular ejection fraction ≤ 40 % and should be clinically stable and on an established treatment regimen for chronic heart failure. - Reduction in the risk of stroke in adult hypertensive patients with left ventricular hypertrophy documented by ECG (see section 5.1: LIFE study, Race). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY Hypertension The usual starting and maintenance dose is 50 mg once daily for most patients. The maximal antihypertensive effect is attained 3 - 6 weeks after initiation of therapy. Some patients may receive an additional benefit by increasing the dose to 100 mg once daily (in the morning). Losartan may be administered with other antihypertensive agents, especially with Read the complete document